SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-016065
Filing Date
2020-08-17
Accepted
2020-08-17 14:30:38
Documents
1
Period of Report
2020-05-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5405
  Complete submission text file 0001493152-20-016065.txt   7091
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Gene Biotherapeutics, Inc. (Issuer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 505 THORNALL STREET STE 304 EDISON NJ 08837
Business Address
MULYE NIRMAL (Reporting) CIK: 0001311267 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33635 | Film No.: 201109380